A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Explore the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures
E2007-G000-208
Study Overview
E2007
perampanel
NCT00416195, 2006-003702-26
Dec 2006 - Mar 2008
Epilepsy
1. Percentage of Responders During the Maintenance Phase [ Time Frame: Day 85 through Day 112]
Males and females 18 Years to 70 Years (Adult, Older Adult)
Completed
Phase
2
Belgium, Estonia, Finland, France, Latvia, Lithuania See moreSee less
The clinical study report (CSR) synopses, plain language results summaries (PLS) and plain language protocol synopses (PLPS) contained on this website are from clinical trials sponsored by Eisai and are provided for informational purposes only. These summaries and synopses contain data from and about the specific study population but do not include patient-level data from each study participant. The results reported in any single trial may not reflect the overall potential risks or benefits associated with Eisai’s products.
Only health care professionals may determine if a specific product is appropriate as a treatment option for a particular patient. Health care professionals should refer to the specific labelling information approved in their country when making prescribing decisions.
The information provided is not intended to commercialize or promote Eisai’s products for any unapproved uses.
All reasonable precautions have been taken to ensure the accuracy, security and confidentiality of information contained on this website. Eisai reserves the right to amend any information on this website at any time at its sole discretion.
If you have questions about any clinical trial results or protocols available on this website, please speak with the doctor, research nurse, or other team member at your trial site.
By clicking “Accept” you are acknowledging that you have read and understood this statement.
Plain Language Protocol Synopsis (PLPS)
No download available
Plain Language Summary of Results (PLS)
No download available
Publication reference citation
Maguire M. Response to “Perampanel and pregnancy: Could experience be a gloomy lantern that does not even illuminate its bearer?”. Epilepsy Behav. 2022 Apr;129:108654. doi: 10.1016/j.yebeh.2022.108654. Epub 2022 Mar 16. No abstract available.
Data Sharing
ClinicalStudyDataRequest.com (CSDR) is a multi sponsor site through which qualified researchers who wish to access clinical trial data and associated information in order to conduct further research can submit their research proposal or enquiry.
CSDR Sharing is available for this study.
CSDR
Availability
Clinical Trial Data
Redacted documents may be available upon request for this study.